Alterations of the retino-cortical conduction in patients affected by Classical Congenital Muscular Dystrophy (Cl-CMD) with merosin deficiency

Documenta Ophthalmologica

Volumn 98, Issue 2, 1999, Pages 127-138

  Tormene, A P ^a   Trevisan, C ^b   Martinello, F ^b   Riva, C ^b   Pastorello, E ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEROSIN;

ADOLESCENT; ADULT; ANTERIOR EYE SEGMENT; ARTICLE; BRAIN CORTEX; CASE REPORT; CHILD; ELECTRORETINOGRAM; EYE FUNDUS; EYE MOVEMENT; EYE REFRACTION; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; MICROGYRIA; MUSCULAR DYSTROPHY; NERVE CONDUCTION; PACHYGYRIA; PROTEIN DEFICIENCY; RETINA; VISUAL ACUITY; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; CHILD; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; IMMUNOBLOTTING; LAMININ; MAGNETIC RESONANCE IMAGING; MALE; MUSCULAR DYSTROPHIES; OPTIC NERVE DISEASES; RETINA; VISUAL ACUITY; VISUAL CORTEX; VISUAL PATHWAYS;

EID: 0033357986     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1002093705611     Document Type: Article

References (22)

1. Fukuyama Y, Kawazura M, Haruna H. A peculiar form of congenital progressive muscular dystrophy. Report of 15 cases. Pediatr Univ. Tokyo (Tokyo) 1960; 4, 5-8.
2. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type- clinical, genetic and pathological considerations. Brain Dev. (Tokyo) 1981; 3: 1-29.
3. Santavuori P, Leisti J, Kruus S. Muscle, eye and brain disease: a new syndrome. Neuropediatrics 1977; 8 (suppl): 553-8.
4. Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev. (Tokyo) 1989; 11: 147-53.
5. Williams R, Swister C, Jennings M, Ambler M, Caviness V. Cerebro-ocular dysgenesis (Walker-Warburg syndrome) neuropathologic and aetiologic analysis. Neurology 1984; 34: 1531-41.
6. Walker AE. Lissencephaly. Arch. Neurol. Psychiatry 1942; 48: 13-20.
7. Dobyns W, Pagon R, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med. Genet 1989; 32: 195-210.
8. Dubowitz V. Workshop report. 22nd ENMC sponsored workshop on congenital muscular dystrophy, Baarn, The Netherlands, 14-16 May 1993. Neuromusc. Disord. 1994; 4: 75-81.
9. Trevisan CP, Carollo C, Segalla P, Angelini C, Drigo P, Giordano R. Congenital muscular dystrophy: brain alterations in an unselected series of Western patients. J Neurol Neurosurg Psychiatry 1991; 54: 330-4.
10. Tomé FMS, Evangelista T, Leclerc A et al. Congenital muscular dystrophy with merosin deficiency. CR Acad. Sci (Paris) /Life Sci 1994; 317: 351-7.
11. Dubowitz V. Exciting new developments in CMD. In: Fukuyama Y. Osawa M., Saito K. eds. Congenital muscular dystrophies. Amsterdam: Elsevier 1997: 21-30.
12. Villanova M, Malandrini A, Sabatelli P, Sewry CA, Toti P, Torelli S, Six J, Scarfo G, Palma L, Muntom F, Squarzoni F, Tosi P, Marladi NM, Guazzi OC. Localisation of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study. Acta Neuropathologica. Dec 1997; 94(6): 567-71.
13. Kamiguchi H, Hlavin ML, Yamasaki M, Lemmon V. Adhesion molecules and inherited diseases of human nervous system. Annual Review of Neuroscience 1998; 21: 97-125.
14. Sewry CA, Uzijel Y, Torelli S, Buchanan S, Sorokin L, Cohen J, Watt DJ. Differential labelling of laminin alpha 2 in muscle and neural tissue of dy/dy mice: are there isoforms of the laminin alpha 2 chain? Neuropathology and applied neurobiology Feb 1998; 24 (1): 66-72.
15. Vuolteenaho R, Nissien M, Sainio K et al. Human laminin M Chain (merosin): complete primary structure, chromosomal assignment and expression of the M and A chains in human foetal tissue. Cell Biol 1994; 124: 381-94.
16. Fardeau MP, Tome FMS, Dubowitz V, Hillaire D. Lifting the lid on congenital muscular dystrophy. Presented at the 8th International Congress on Neuromuscular Disease, Kyoto, 1994.
17. Trevisan CP, Martinello F, Fanin M, Carollo C, Pen P, Angelini C, Drigo P, Laverda AM, Mostacciuolo ML, Tormene AP, Fardeau M, Tome FMS. Longitudinal evaluation of leukoencephalopathy in congenital muscular dystrophy: data on a heterogeneous series of western cases. In Y Fukuyama, M Osawa and K Saito (eds.), Congenital Muscular Dystrophies, Elsevier Science B.V. (Amsterdam, The Netherlands) 1997, pp 137-45.
18. Fardeau MP, Tome FMS. Clinical and immunological evidence of heterogeneity in classical (occidental) congenital muscular dystrophy. In: Fukuyama Y, Osawa M, Saito K, eds. Congenital muscular dystrophies. Amsterdam: Elsevier 1997; 79-87.
19. Martinello F, Angelini C, Trevisan CP. Congenital Muscular Dystrophy with partial merosin deficiency and late onset epilepsy. Eur Neurol 1998; 40: 37-45.
20. Leyten QH, Gabreels M, Reiner WO, Renkawek K, der Laak HJ, Mullart RA. Congenital muscular dystrophy with eye and brain malformations in six Dutch patients. Neuropediatrics 1992; 23: 316-20.
21. Pihko H, Santavuori P. Muscle-eye-brain (MEB) disease - a review. In: Fukuyama Y, Osawa M, Saito K, eds. Congenital Muscular Dystrophies, 1997. Elsevier Science, 99-104.
22. Mercuri E, Muntoni F, Bernardinelli A, Pennock J, Sewry C, Philpot J, Dubowitz V. Somatosensory and Visual Evoked Potentials in Congenital Muscular Dystrophy: Correlation with MRI Changes and Muscle Merosin Status. Neuropediatrics 1995; 26: 3-7.